header logo image

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024

May 14th, 2024 2:34 am

BOSTON and LONDON, May 13, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today reported financial results and business highlights for the first quarter ended March 31, 2024.

See the original post here:
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024

Related Post

Comments are closed.


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick